about
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approachAmplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancerGene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancerComparative meta-analysis of prognostic gene signatures for late-stage ovarian cancerPublic data and open source tools for multi-assay genomic investigation of diseaseAssessment of pharmacogenomic agreementAngiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancerEnhancing reproducibility in cancer drug screening: how do we move forward?curatedOvarianData: clinically annotated data for the ovarian cancer transcriptomeSimilarity network fusion for aggregating data types on a genomic scale.Inference and validation of predictive gene networks from biomedical literature and gene expression data.BatchQC: interactive software for evaluating sample and batch effects in genomic data.Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?Comparison of prognostic gene expression signatures for breast cancerThe Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial.Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AMLLong-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cellsAn imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS).Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER statusLoss of Pgc-1α expression in aging mouse muscle potentiates glucose intolerance and systemic inflammationA fuzzy gene expression-based computational approach improves breast cancer prognosticationPIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response.Multiple-input multiple-output causal strategies for gene selection.Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.Functional and genetic analysis of the colon cancer network.CT-based radiomic signature predicts distant metastasis in lung adenocarcinomaRadiomic feature clusters and prognostic signatures specific for Lung and Head & Neck cancer.Inconsistency in large pharmacogenomic studies.DNA replication stress: a source of APOBEC3B expression in breast cancerSignificance analysis of prognostic signatures.Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosismRMRe: an R package for parallelized mRMR ensemble feature selection.Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification.Medulloblastoma subgroups remain stable across primary and metastatic compartments.APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
P50
Q23760721-F42C7786-3E04-4FFF-94C1-8E8BD8AA9230Q24644185-87C1CFE2-85FC-499F-AEF2-C75658A1C3D5Q24652481-17EB527B-FC37-4696-893E-1EEF82F40EEAQ26859166-FE5ADDF4-2ECB-4684-9270-3FF8C6E0ED4BQ28596241-74A6B764-AAF0-490A-88DE-ABACA948C02EQ28597117-94DDB85B-CD93-4263-AE99-1293FDF27AA3Q28732124-786F1C69-691F-4F24-B8AD-73DCD1B335BFQ30405622-DBEEF855-603C-43EE-9641-962DDD84E30BQ30611147-64D004F5-703E-4A20-A50E-9737231A1417Q30742291-0250CAC6-19B7-4F45-BAE0-7C35894FB0F7Q30791224-0077E68A-FBF4-4EA6-86D8-E8148DD95456Q31122464-FFC9254C-1A89-438D-B9F9-3596EB8B84EDQ33337206-3750E7CC-5A2B-4D3A-8A5E-31DB9A7ED642Q33352632-1D64EA07-5CD3-4A7B-BBFC-A48ACDCD66ABQ33362164-1A5F9F0C-4A99-4FD7-A13B-6800849BFAC6Q33477635-90B959CB-4162-4451-B9DA-3821BA63F3F2Q33501853-2BD488DF-7189-443C-802C-8DA7F99B704BQ33556923-62F034C7-6B81-4B2C-B86E-8DEACDBEAD3EQ33588294-39EE0D46-315B-4DF0-AABE-3E543C7CAAD4Q33692066-AC5A3BF3-A178-4B61-BF77-64DEAAE90120Q33697985-BEBC6FEC-5599-4BEB-BF44-FEA4D2270560Q33769803-60AFDDB6-322F-4DC2-B506-1F11687F729CQ33816920-EC3E101F-224D-4DBB-A515-46EE9236530EQ33861620-61837C10-D058-46F4-BC68-2B05FF60CF7BQ33933172-1EC447DB-E9FD-4987-83A6-D1830D6392B9Q33974305-1B405585-69F3-4910-8ED5-FC63477362F9Q34083912-7B532754-9B32-43C7-857F-A7390C7E9623Q34105361-5133ECD6-38F3-4BBB-8EB5-B0B7A69028C7Q34153290-DEFAE56F-FEB0-4B79-BDC5-2E457ECA1A41Q34466023-2C2E1187-6D59-4C01-82F4-91ED2771896AQ34488635-3AD24061-852E-4695-AEB2-7812B4C90D2CQ34541198-6C429D22-BC95-4B8F-AB45-6CD4D66C543BQ34542213-6E0A0D04-BC91-4FBB-ADA2-6201BB411757Q34568149-9BC117DA-0F0A-410A-B229-2690C2EBF404Q34639023-AD85F72F-488B-4431-A7A9-1C52413E49F8Q34793900-AEF8BB5C-3403-4071-B591-96AC00C75D84Q34897615-66978DD0-395F-414B-AADC-FEC10A657703Q34922055-0D3FE330-20CD-4147-AC95-8DBD2032D973Q35099027-F9AFE47D-1C5E-40B4-85FD-C039C64068ABQ35156922-B10F9109-CA33-42A3-A7E2-13DE820E3B9E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Benjamin Haibe-Kains
@ast
Benjamin Haibe-Kains
@en
Benjamin Haibe-Kains
@es
Benjamin Haibe-Kains
@sl
type
label
Benjamin Haibe-Kains
@ast
Benjamin Haibe-Kains
@en
Benjamin Haibe-Kains
@es
Benjamin Haibe-Kains
@sl
prefLabel
Benjamin Haibe-Kains
@ast
Benjamin Haibe-Kains
@en
Benjamin Haibe-Kains
@es
Benjamin Haibe-Kains
@sl
P1053
D-3702-2011
P106
P1153
23667678400
P21
P2456
P31
P3829
P496
0000-0002-7684-0079